A tool for spotting pancreatic cancer in routine CT scans has had promising results, one example of how China is racing to ...

The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...

Despite medical advances, pancreatic cancer remains notoriously lethal. Here's why it's so hard to catch—and even harder to treat.

One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical ...

HUTCHMED (China) ( ($HK:0013) ) just unveiled an update. HUTCHMED has initiated the Phase III stage of an ongoing Phase II/III clinical trial in ...

Everyday habits such as heavy drinking and unhealthy eating can gradually damage the pancreas. Once injured, the consequences ...

Final results from the phase 3 CASSANDRA trial presented at the 2025 ASCO Meeting show that the neoadjuvant chemotherapy ...

Three days after Qiu Sijun, a retired bricklayer in eastern China, went for a routine diabetes checkup, he received a call from a doctor he ...

Former Secretary of State Condoleezza Rice posted a statement from Hoover Institution Senior Fellow Victor Davis Hanson on ...

The feature, known as “AI Overview,” appears at the top of Google search results and provides brief, AI-generated summaries ...

Google's AI search summaries are giving dangerous health advice, from telling pancreatic cancer patients to avoid fats to ...